MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
3135.08%
Quick Ratio
3135.08%
Cash Ratio
470.64%
Debt to Asset Ratio
4.09%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Restricted cash
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
48,466
50,261
197,533
47,078
Marketable securities
270,374
283,055
154,773
153,567
Unbilled accounts receivable
-
-
0
0
Prepaid expenses and other current assets
4,011
5,353
5,174
5,218
Total current assets
322,851
338,669
357,480
205,863
Total property and equipment
-
17,719
18,471
18,471
Less accumulated depreciation
-
15,225
15,647
15,300
Property and equipment, net
0
2,494
2,824
3,171
Operating lease right-of-use assets
0
3,860
4,241
4,614
Restricted cash
1,092
1,201
1,201
1,201
Other assets
9
546
538
9
Total assets
323,952
346,770
366,284
214,858
Accounts payable
3,425
2,450
1,592
2,856
Accrued expenses and other current liabilities
4,355
4,953
9,052
6,428
Operating lease liability, current
2,518
2,461
2,404
2,348
Total current liabilities
10,298
9,864
13,048
11,632
Operating lease liability, excluding current portion
2,760
3,406
4,039
4,663
Other liabilities, excluding current portion
197
197
197
197
Total liabilities
13,255
13,467
17,284
16,492
Common stock, 0.001 par value 200,000,000 shares authorized 76,285,157 and 66,578,891 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
76
67
67
54
Additional paid-in capital
950,536
946,918
943,037
772,015
Accumulated other comprehensive (loss) gain
-567
-513
174
241
Accumulated deficit
-639,348
-613,169
-594,278
-573,944
Total stockholders equity
310,697
333,303
349,000
198,366
Total liabilities and stockholders equity
323,952
346,770
366,284
214,858
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$270,374K (57.63%↑ Y/Y)Cash and cashequivalents$48,466K (13.80%↑ Y/Y)Prepaid expenses andother current assets$4,011K (-23.77%↓ Y/Y)Total current assets$322,851K (47.17%↑ Y/Y)Restricted cash$1,092K (-9.38%↓ Y/Y)Other assets$9K (-25.00%↓ Y/Y)Total assets$323,952K (41.56%↑ Y/Y)Total liabilities andstockholders equity$323,952K (41.56%↑ Y/Y)Total stockholdersequity$310,697K (44.93%↑ Y/Y)Total liabilities$13,255K (-8.33%↓ Y/Y)Accumulated deficit-$639,348K (-15.33%↓ Y/Y)Accumulated othercomprehensive (loss) gain-$567K (-791.46%↓ Y/Y)Additional paid-in capital$950,536K (23.67%↑ Y/Y)Total currentliabilities$10,298K (14.61%↑ Y/Y)Operating leaseliability, excluding...$2,760K (-47.71%↓ Y/Y)Other liabilities,excluding current portion$197K (0.00%↑ Y/Y)Common stock, 0.001 parvalue 200,000,000...$76K (40.74%↑ Y/Y)Accrued expenses andother current...$4,355K (-11.86%↓ Y/Y)Accounts payable$3,425K (95.60%↑ Y/Y)Operating leaseliability, current$2,518K (9.81%↑ Y/Y)

Fulcrum Therapeutics, Inc. (FULC)

Fulcrum Therapeutics, Inc. (FULC)